BK

Bhupendra Kulshrestha

Director DIN 02787516
DIN 02787516 First appointment Sep 2009
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhupendra Kulshrestha

Data last updated:

Bhupendra Kulshrestha was a Director at Core Infusion Private Limited (from 2010) and Director at Kore Life Sciences Private Limited (from 2009).

DIN 02787516
First Appointment 22 Sep 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Core Infusion Private Limited U24230MP2010PTC022905
Director07 Jan 20102010Strike Off
Kore Life Sciences Private Limited U24230MP2008PTC021287
Director22 Sep 20092008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Core Infusion Private Limited
Kore Life Sciences Private Limited
Premium access

Shareholding and investment profile for Bhupendra Kulshrestha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhupendra Kulshrestha

Bhupendra Kulshrestha was first appointed on 22 Sep 2009 as Director at Kore Life Sciences Private Limited. The most recent appointment on record is 07 Jan 2010 at Core Infusion Private Limited.

Bhupendra Kulshrestha held 2 earlier board appointments: Core Infusion Private Limited (Director, from 07 Jan 2010); Kore Life Sciences Private Limited (Director, from 22 Sep 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available